Other OTC Pharmaceuticals - ASEAN

ASEAN

Highlights

In ASEAN, the revenue generated in the market Other OTC Pharmaceuticals amounts to US$1.15bn in 2024.
It is projected that this market will experience an annual growth rate of 2.24% (CAGR 2024-2029).
When compared globally, the United States leads the pack, generating a revenue of US$7.17bn in 2024.
In terms of per capita figures, each person in ASEAN contributes US$1.67 in revenue in 2024.
ASEAN countries are witnessing a rising demand for Other OTC Pharmaceuticals, driven by increasing awareness of the benefits of self-medication and accessibility of non-prescription drugs.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in ASEAN is experiencing significant growth and development due to several key factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the expansion of this industry in the region.Customer preferences play a crucial role in the growth of the Other OTC Pharmaceuticals market in ASEAN. Consumers in this region have shown a growing preference for self-medication and over-the-counter remedies for minor ailments. This shift in consumer behavior can be attributed to increasing awareness and education about healthcare, as well as the convenience and accessibility of OTC products. Additionally, the rising middle class in ASEAN countries has led to increased purchasing power and a greater demand for healthcare products.Trends in the market further drive the growth of the Other OTC Pharmaceuticals industry in ASEAN. One notable trend is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of synthetic drugs and are seeking alternative options. This has led to a surge in demand for herbal and natural OTC products, which are perceived as safer and more sustainable. Manufacturers and retailers are capitalizing on this trend by expanding their product offerings in this category.Local special circumstances also contribute to the development of the Other OTC Pharmaceuticals market in ASEAN. Each country in the region has its own unique healthcare system, regulations, and cultural practices that influence consumer behavior and market dynamics. For example, in countries like Indonesia and the Philippines with large rural populations, access to healthcare facilities and professionals may be limited. This drives the demand for OTC products as a convenient and cost-effective solution for minor health issues.Underlying macroeconomic factors also play a significant role in the growth of the Other OTC Pharmaceuticals market in ASEAN. The region has been experiencing rapid economic growth, leading to an increase in disposable income and healthcare expenditure. As the standard of living improves and healthcare becomes more affordable, consumers are more willing to spend on OTC products. Additionally, favorable government policies and regulations that promote the development of the pharmaceutical industry further stimulate market growth.In conclusion, the Other OTC Pharmaceuticals market in ASEAN is developing due to customer preferences for self-medication, trends in the market such as the popularity of natural remedies, local special circumstances that drive demand for OTC products, and underlying macroeconomic factors including economic growth and favorable government policies. This industry is expected to continue growing as consumer awareness and purchasing power increase in the region.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.